ArticleRheumatology and therapy2022

Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs.

Vardhaman Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.